|
Dec 18
|
TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC
|
|
Nov 30
|
TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors
|
|
Nov 30
|
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
|
|
Nov 27
|
TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023
|
|
Sep 28
|
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
|